Suresh C Jhanwar

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi request reprint Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview
    Suresh C Jhanwar
    Departments of Pathology and Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA Electronic address
    Adv Biol Regul 58:28-37. 2015
  2. doi request reprint Genetic abnormalities in non-Hodgkin's lymphoma as revealed by conventional and molecular cytogenetics methods of analyses
    Suresh C Jhanwar
    Department of Pathology, Molecular Diagnostic Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Methods Mol Biol 730:131-48. 2011
  3. pmc International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
    Andrew B Lassman
    Department of Neurology and Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Neuro Oncol 13:649-59. 2011
  4. pmc MET expression and amplification in patients with localized gastric cancer
    Yelena Y Janjigian
    Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY 10065, USA
    Cancer Epidemiol Biomarkers Prev 20:1021-7. 2011
  5. pmc Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings
    Hugo Castro-Malaspina
    The Allogeneic Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Biol Blood Marrow Transplant 14:458-68. 2008
  6. pmc Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma
    Brian H Kushner
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Pediatr Blood Cancer 53:17-22. 2009
  7. doi request reprint Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization
    Klaus J Busam
    Department of Pathology, Ophthalmologic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Cutan Pathol 37:196-203. 2010
  8. doi request reprint Feasibility of ex vivo FDG PET of the colon
    Marc J Gollub
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10023, USA
    Radiology 252:232-9. 2009
  9. ncbi request reprint Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1
    Yuqiang Fang
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Anticancer Res 29:1255-62. 2009
  10. doi request reprint Teratocarcinosarcoma of the nasal cavity and paranasal sinuses: report of 3 cases with assessment for chromosome 12p status
    Fadi Salem
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Hum Pathol 39:605-9. 2008

Collaborators

Detail Information

Publications13

  1. doi request reprint Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview
    Suresh C Jhanwar
    Departments of Pathology and Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA Electronic address
    Adv Biol Regul 58:28-37. 2015
    ..Several drugs which either target the spliceosome, oncogenic RAS signaling, or hypomethylating agents have been employed to successfully treat MDS patients. ..
  2. doi request reprint Genetic abnormalities in non-Hodgkin's lymphoma as revealed by conventional and molecular cytogenetics methods of analyses
    Suresh C Jhanwar
    Department of Pathology, Molecular Diagnostic Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Methods Mol Biol 730:131-48. 2011
    ....
  3. pmc International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
    Andrew B Lassman
    Department of Neurology and Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Neuro Oncol 13:649-59. 2011
    ..Combined CT + RT led to longer disease control and survival than did CT or RT alone in cases with no 1p19q deletion. Ongoing trials will address these issues prospectively...
  4. pmc MET expression and amplification in patients with localized gastric cancer
    Yelena Y Janjigian
    Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY 10065, USA
    Cancer Epidemiol Biomarkers Prev 20:1021-7. 2011
    ..MET, the receptor for hepatocyte growth factor, has been proposed as a therapeutic target in gastric cancer. This study assessed the incidence of MET expression and gene amplification in tumors of Western patients with gastric cancer...
  5. pmc Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings
    Hugo Castro-Malaspina
    The Allogeneic Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Biol Blood Marrow Transplant 14:458-68. 2008
    ....
  6. pmc Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma
    Brian H Kushner
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Pediatr Blood Cancer 53:17-22. 2009
    ..We report a prospective study of secondary leukemia (SL)/myelodysplastic syndrome (MDS) in neuroblastoma (NB) patients treated with > or =5 cycles of dose-intensive chemotherapy...
  7. doi request reprint Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization
    Klaus J Busam
    Department of Pathology, Ophthalmologic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Cutan Pathol 37:196-203. 2010
    ..The findings encourage further exploration of this technique as an ancillary method for the work-up of conjunctival melanocytic proliferations...
  8. doi request reprint Feasibility of ex vivo FDG PET of the colon
    Marc J Gollub
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10023, USA
    Radiology 252:232-9. 2009
    ....
  9. ncbi request reprint Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1
    Yuqiang Fang
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Anticancer Res 29:1255-62. 2009
    ..These cell lines with extensive characterization of genetic abnormalities are likely to provide important reagents for biochemical, molecular and pharmacological studies related to MPNST...
  10. doi request reprint Teratocarcinosarcoma of the nasal cavity and paranasal sinuses: report of 3 cases with assessment for chromosome 12p status
    Fadi Salem
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Hum Pathol 39:605-9. 2008
    ..Our findings suggest that 12p amplification, if it occurs at all in this setting, is exceptional and that SNTCS is a somatic-type neoplasm exhibiting divergent differentiation rather than a germ cell tumor...
  11. ncbi request reprint Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH): an alternative and practical method
    Rohit Bhargava
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Diagn Mol Pathol 14:72-6. 2005
    ..We conclude that CISH is an accurate method for determining MYCN gene amplification, with added advantages that make it a more practically useful method...
  12. ncbi request reprint Molecular cytogenetic analysis of genomic instability at the 1q12-22 chromosomal site in B-cell non-Hodgkin lymphoma
    Takahiro Itoyama
    Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Genes Chromosomes Cancer 35:318-28. 2002
    ..Chromosome arm 1q is gene-rich, and characterization of aberrations described in this study can be expected to lead to the discovery of additional functionally significant genetic changes...
  13. ncbi request reprint Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma
    Gouri Nanjangud
    Cell Biology Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Blood 99:2554-61. 2002
    ..These studies emphasize the value of SKY analysis for redefinition of chromosomal instability in DLBCL to enhance gene discovery as well as clinical correlation analysis...